Seventeen year risk of all-cause and cause-specific mortality associated with C-reactive protein, fibrinogen and leukocyte count in men and women: the EPIC-Norfolk study

被引:72
作者
Ahmadi-Abhari, Sara [1 ]
Luben, Robert N. [1 ]
Wareham, Nicholas J. [2 ]
Khaw, Kay-Tee [3 ]
机构
[1] Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge CB1 8RN, England
[2] Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England
[3] Addenbrookes Hosp, Clin Gerontol Unit, Dept Publ Hlth & Primary Care, Cambridge CB2 2QQ, England
基金
英国医学研究理事会;
关键词
Mortality; Cardiovascular disease; Inflammation; Ageing; C-reactive protein; Fibrinogen; Leukocyte count; Cohort study; CORONARY-HEART-DISEASE; BLOOD-CELL COUNT; NECROSIS-FACTOR-ALPHA; INFLAMMATORY MARKERS; PHYSICAL-ACTIVITY; CANCER-RISK; INCIDENT CORONARY; BODY-COMPOSITION; HEALTHY-MEN; INTERLEUKIN-6;
D O I
10.1007/s10654-013-9819-6
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
There is strong evidence from observational studies suggesting serum C-reactive protein (CRP) is associated with cardiovascular and all-cause mortality. However, less is known about whether there are differences in the association of CRP with all-cause or cause specific mortality by sex, smoking, body mass index (BMI), or physical activity. We aimed to investigate these interactions and also investigate and compare the association of CRP and other inflammation markers (i.e., fibrinogen and leukocyte count) with all-cause and cause-specific mortality. Men and women aged 40-79 were recruited in 1993-1997 in the EPIC-Norfolk cohort study. A total of 16,850 participants with high-sensitivity assayed CRP data who had no known cancer, myocardial infarction and stroke at baseline were entered in the analysis to test the association of CRP, fibrinogen and leukocyte count with risk of all-cause and cause specific mortality. A total of, 2,603 all-cause deaths (1,452 in men) including 823 cardiovascular and 1,035 cancer deaths, were observed after 231,000 person-years of follow-up (median 14.3 years). CRP was positively associated with risk of all-cause, cardiovascular, and non-cancer non-cardiovascular mortality independent of established risk factors. The hazard ratio of all-cause mortality (95 % CI) for participants with CRP in the range of 3-10 and > 10 mg/l (vs. < 0.5 mg/l) was 1.56 (1.26-1.93) and 1.87 (1.43-2.43) respectively in men and 1.34 (1.07-1.68) and 1.98 (1.50-2.63) in women. The association was less positively graded in women with the increased risk being significant only at higher levels of the CRP distribution. The association persisted in never smokers and did not vary by levels of BMI or physical activity. Although fibrinogen and leukocyte count were also positively associated with mortality risk, only CRP remained a significant predictor of mortality when the inflammation markers were adjusted for one another in multivariable models. Serum CRP levels were a long-term predictor of risk of cardiovascular and non-cardiovascular mortality independent of known risk factors, fibrinogen, and leukocyte count.
引用
收藏
页码:541 / 550
页数:10
相关论文
共 51 条
[1]   CRP after 2004 [J].
Agrawal, A .
MOLECULAR IMMUNOLOGY, 2005, 42 (08) :927-930
[2]   Effect of freezing method and storage at-20 °C and-70 °C on prothrombin time, aPTT and plasma fibrinogen levels [J].
Alesci, Sonja ;
Borggrefe, Martin ;
Dempfle, Carl-Erik .
THROMBOSIS RESEARCH, 2009, 124 (01) :121-126
[3]   C-Reactive Protein and the Risk of Cancer: A Mendelian Randomization Study [J].
Allin, Kristine H. ;
Nordestgaard, Borge G. ;
Zacho, Jeppe ;
Tybjaerg-Hansen, Anne ;
Bojesen, Stig E. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (03) :202-206
[4]   C reactive protein and its determinants in healthy men and women from European regions at different risk of coronary disease: the IMMIDIET Project [J].
Arcari, A. ;
Zito, F. ;
Di Castelnuovo, A. ;
De Curtis, A. ;
Dirckx, C. ;
Arnout, J. . ;
Cappuccio, F. P. ;
Van Dongen, M. C. J. M. ;
De Lorgeril, M. ;
Krogh, V. ;
Siani, A. ;
Donati, M. B. . ;
De Gaetano, G. ;
Iacoviello, L. . .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (03) :436-443
[5]   High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese - The Hisayama study [J].
Arima, Hisatomi ;
Kubo, Michiaki ;
Yonemoto, Koji ;
Doi, Yasufumi ;
Ninomiya, Toshiharu ;
Tanizaki, Yumihiro ;
Hata, Jun ;
Matsumura, Kiyoshi ;
Iida, Mitsuo ;
Kiyohara, Yutaka .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (07) :1385-1391
[6]   Estrogen is a modulator of vascular inflammation [J].
Chakrabarti, Subhadeep ;
Lekontseva, Olga ;
Davidge, Sandra T. .
IUBMB LIFE, 2008, 60 (06) :376-382
[7]   C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease [J].
Dahl, Morten ;
Vestbo, Jorgen ;
Lange, Peter ;
Bojesen, Stig E. ;
Tybjaerg-Hansen, Anne ;
Nordestgaard, Borge G. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 175 (03) :250-255
[8]   Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality - An individual participant meta-analysis [J].
Danesh, J ;
Lewington, S ;
Thompson, SG ;
Lowe, GDO ;
Collins, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (14) :1799-1809
[9]   Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease - Meta-analyses of prospective studies [J].
Danesh, J ;
Collins, R ;
Appleby, P ;
Peto, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18) :1477-1482
[10]   C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease [J].
Danesh, J ;
Wheeler, JG ;
Hirschfield, GM ;
Eda, S ;
Eiriksdottir, G ;
Rumley, A ;
Lowe, GDO ;
Pepys, MB ;
Gudnason, V .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (14) :1387-1397